ka.castellanos
Submits third-party assay reports on material purchased directly. Based in Łódź.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
98.72%
n=10
Suppliers covered
8
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041273 | Liraglutide | WWB | WWB-2607-X2189 | Janoshik | 2026-Q3 | 99.31 | 5.52 | 104.8 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043096 | Retatrutide | KP | KP-2607-H5774 | VendorInvestigate | 2026-Q3 | 96.48 | 6.05 | 104.9 | Buyer-sourced | 0 | FAIL |
| AX-2026-043617 | Tirzepatide | PPG | PPG-2602-G7459 | Janoshik | 2026-Q2 | 98.94 | 4.36 | 103.6 | Buyer-sourced | 0 | PASS |
| AX-2026-042252 | BPC-157 | TFC | TFC-2511-S9305 | Janoshik | 2026-Q2 | 98.28 | 5.09 | 94.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043306 | Retatrutide | CPC | CPC-2604-H1694 | Janoshik | 2026-Q2 | 97.04 | 3.78 | 96.4 | Buyer-sourced | 0 | PASS |
| AX-2025-019852 | Semaglutide | Homopeptide | HOMO-2509-F5826 | Kestrel | 2025-Q4 | 99.93 | 4.40 | 103.9 | Supplier-supplied | 0 | PASS |
| AX-2025-019617 | BPC-157 | TFC | TFC-2508-W1453 | Medutest | 2025-Q3 | 99.93 | 3.54 | 89.8 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018945 | Retatrutide | ASY | ASY-{CAT}-1860 | Janoshik | 2025-Q3 | 98.25 | 5.77 | 99.0 | Buyer-sourced | 0 | PASS |
| AX-2025-020123 | MGF | ERP | ERP-2501-B8503 | Janoshik | 2025-Q1 | 98.51 | 3.08 | 93.0 | Buyer-sourced | 0 | PASS |
| AX-2024-004757 | Survodutide | Homopeptide | HOMO-2406-F5091 | Janoshik | 2024-Q4 | 99.42 | 5.35 | 95.9 | Buyer-sourced | 0 | PASS |